Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine

Chi-Cheng Wu, Yi-Ru Chen, Pao Luh Tao, Yi Ann Chen, Geng Chang Yeh

研究成果: 雜誌貢獻文章

11 引文 (Scopus)

摘要

Previous investigations had shown that inhibitor of serotonin reuptake transporter (SERT) could attenuate morphine withdrawal syndrome in adult animals. In the present study, we determined whether postnatal injection of serotonin reuptake inhibitors, fluoxetine, clomipramine, or citalopram, is able to attenuate the expression of the naloxone-precipitated morphine withdrawal syndrome in 5-day-old neonatal Sprauge-Dawley rats born to dams rat that received morphine injection since a week before mating till 5 days after delivery. Withdrawal syndrome of morphine, manifested as frequent abdominal stretching and yawning, was generated by injection of naloxone on postnatal day 5. Pre-injection with fluoxetine, clomipramine, or citalopram, significantly attenuated the naloxone-precipitated syndrome in a dose-dependent manner without apparent side effect. The rank order of inhibitory potency is citalopram=clomipramine>fluoxetine. This result suggests that inhibitor of SERT may be of potential in treating neonatal morphine withdrawal syndrome.
原文英語
頁(從 - 到)37-42
頁數6
期刊European Journal of Pharmacology
512
發行號1
DOIs
出版狀態已發佈 - 四月 4 2005

指紋

Neonatal Abstinence Syndrome
Serotonin Uptake Inhibitors
Morphine
Clomipramine
Citalopram
Fluoxetine
Naloxone
Serotonin Plasma Membrane Transport Proteins
Injections
Yawning

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

引用此文

Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine. / Wu, Chi-Cheng; Chen, Yi-Ru; Tao, Pao Luh; Chen, Yi Ann; Yeh, Geng Chang.

於: European Journal of Pharmacology, 卷 512, 編號 1, 04.04.2005, p. 37-42.

研究成果: 雜誌貢獻文章

Wu, Chi-Cheng ; Chen, Yi-Ru ; Tao, Pao Luh ; Chen, Yi Ann ; Yeh, Geng Chang. / Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine. 於: European Journal of Pharmacology. 2005 ; 卷 512, 編號 1. 頁 37-42.
@article{556777dd37314ba39f4e5ccfdc15e98f,
title = "Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine",
abstract = "Previous investigations had shown that inhibitor of serotonin reuptake transporter (SERT) could attenuate morphine withdrawal syndrome in adult animals. In the present study, we determined whether postnatal injection of serotonin reuptake inhibitors, fluoxetine, clomipramine, or citalopram, is able to attenuate the expression of the naloxone-precipitated morphine withdrawal syndrome in 5-day-old neonatal Sprauge-Dawley rats born to dams rat that received morphine injection since a week before mating till 5 days after delivery. Withdrawal syndrome of morphine, manifested as frequent abdominal stretching and yawning, was generated by injection of naloxone on postnatal day 5. Pre-injection with fluoxetine, clomipramine, or citalopram, significantly attenuated the naloxone-precipitated syndrome in a dose-dependent manner without apparent side effect. The rank order of inhibitory potency is citalopram=clomipramine>fluoxetine. This result suggests that inhibitor of SERT may be of potential in treating neonatal morphine withdrawal syndrome.",
keywords = "Morphine withdrawal syndrome, Naloxone, Neonatal rat, Serotonin reuptake transporter inhibitor",
author = "Chi-Cheng Wu and Yi-Ru Chen and Tao, {Pao Luh} and Chen, {Yi Ann} and Yeh, {Geng Chang}",
year = "2005",
month = "4",
day = "4",
doi = "10.1016/j.ejphar.2005.02.002",
language = "English",
volume = "512",
pages = "37--42",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine

AU - Wu, Chi-Cheng

AU - Chen, Yi-Ru

AU - Tao, Pao Luh

AU - Chen, Yi Ann

AU - Yeh, Geng Chang

PY - 2005/4/4

Y1 - 2005/4/4

N2 - Previous investigations had shown that inhibitor of serotonin reuptake transporter (SERT) could attenuate morphine withdrawal syndrome in adult animals. In the present study, we determined whether postnatal injection of serotonin reuptake inhibitors, fluoxetine, clomipramine, or citalopram, is able to attenuate the expression of the naloxone-precipitated morphine withdrawal syndrome in 5-day-old neonatal Sprauge-Dawley rats born to dams rat that received morphine injection since a week before mating till 5 days after delivery. Withdrawal syndrome of morphine, manifested as frequent abdominal stretching and yawning, was generated by injection of naloxone on postnatal day 5. Pre-injection with fluoxetine, clomipramine, or citalopram, significantly attenuated the naloxone-precipitated syndrome in a dose-dependent manner without apparent side effect. The rank order of inhibitory potency is citalopram=clomipramine>fluoxetine. This result suggests that inhibitor of SERT may be of potential in treating neonatal morphine withdrawal syndrome.

AB - Previous investigations had shown that inhibitor of serotonin reuptake transporter (SERT) could attenuate morphine withdrawal syndrome in adult animals. In the present study, we determined whether postnatal injection of serotonin reuptake inhibitors, fluoxetine, clomipramine, or citalopram, is able to attenuate the expression of the naloxone-precipitated morphine withdrawal syndrome in 5-day-old neonatal Sprauge-Dawley rats born to dams rat that received morphine injection since a week before mating till 5 days after delivery. Withdrawal syndrome of morphine, manifested as frequent abdominal stretching and yawning, was generated by injection of naloxone on postnatal day 5. Pre-injection with fluoxetine, clomipramine, or citalopram, significantly attenuated the naloxone-precipitated syndrome in a dose-dependent manner without apparent side effect. The rank order of inhibitory potency is citalopram=clomipramine>fluoxetine. This result suggests that inhibitor of SERT may be of potential in treating neonatal morphine withdrawal syndrome.

KW - Morphine withdrawal syndrome

KW - Naloxone

KW - Neonatal rat

KW - Serotonin reuptake transporter inhibitor

UR - http://www.scopus.com/inward/record.url?scp=16244366790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16244366790&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2005.02.002

DO - 10.1016/j.ejphar.2005.02.002

M3 - Article

C2 - 15814088

AN - SCOPUS:16244366790

VL - 512

SP - 37

EP - 42

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -